Calcium Channel Blockers in Veterinary Medicine
Authors:
Open Access
- 1 May 1998
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 12 (3) , 123-131
Abstract
Abstarct: Calcium channel blockers are becoming increasingly popular in veterinary medicine for the treatment of systemic hypertension, cardiac arrhythmias, and hypertrophic cardiomyopathy. Calcium is vital to many cellular functions and thus stringent regulation of intracellular calcium concentrations is required. Pharmacologic manipulation of the regulatory mechanisms has the potential to alter cellular function in all body systems. In human medicine, calcium channel blockers are being evaluated for, among other things, use in treating glaucoma, deep vein thrombosis, and pulmonary hypertension, in renal transplantation, and for prevention of reperfusion injury. The potentially beneficial effects of these drugs have often been overshadowed by adverse effects including hypotension, inappetence, bradycardia, conduction abnormalities, and decreased cardiac output. With the introduction of sustained- release formulations (diltiazem) and 2nd generation calcium channel blockers (amlodipine) many of these effects have been attenuated or eliminated. This paper will review the functions of calcium and the calcium channels as well as discussing the classes and current and potential uses of the various calcium channel blockers.Keywords
This publication has 49 references indexed in Scilit:
- AmlodipineDrugs, 1995
- Hypertension After Renal TransplantationHypertension, 1995
- Clinical Pharmacokinetics of Calcium AntagonistsClinical Pharmacokinetics, 1992
- Clinical Pharmacokinetics of AmlodipineClinical Pharmacokinetics, 1992
- Cardioprotective effects of amlodipine in the ischemic-repefused heartThe American Journal of Cardiology, 1989
- Protection of regional mechanics and mitochondrial oxidative phosphorylation by amlodipine in transiently ischemic myocardiumThe American Journal of Cardiology, 1989
- Inhibition by amlodipine of activity evoked in isolated human coronary arteries by endothelin, prostaglandin F2α and depolarizationThe American Journal of Cardiology, 1989
- Effects of amlodipine on myocardial ischemia-reperfusion injury in dogsThe American Journal of Cardiology, 1989
- Hemodynamic and electrophysiologic effects of amlodipine, a new calcium channel blockerThe American Journal of Cardiology, 1989
- The pharmacokinetic profile of amlodipineAmerican Heart Journal, 1989